Search This Blog

Monday, July 22, 2019

Rapt Therapeutics sets IPO terms

Rapt Therapeutics (RAPT) will offer 5M common shares at $14 – 16 per share in its IPO. Underwriters over-allotment will be an additional 750K shares.
Certain stockholders have indicated an interest in buying $25M of the offering.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)